Clinical Trial Update: ScentAware and OCT in MCI vs HC

View source ↗

Summary

The clinical trial evaluating ScentAware and OCT in individuals with mild cognitive impairment versus healthy controls, related to early-onset Alzheimer disease…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease Early Onset
• Cognitive Impairment

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Alzheimer Disease, Early Onset | Status: TERMINATED